Sphera Biotech US Fund, L.P.
Amendment
CIK: 0001749475·Pooled Investment Fund·DELAWARE·Filed: Apr 27, 2026
Total Offering
Indefinite
Amount Sold
$32,071,088
Investors
11
First Sale
Oct 1, 2018
Offering Details
- Type
- Pooled Investment Fund
- Exemptions
- Rule 506(b), Section 3(c), Section 3(c)(7)
- Entity Type
- Limited Partnership
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| DORON BREEN | |
| NIR ARKIN | |
| ADI HANETZ | |
| HANNA LERMAN |
Company
Sphera Biotech US Fund, L.P.
SPHERA GLOBAL HEALTHCARE MANAGEMENT, LP
TEL AVIV, L3, 6777520
972-3-6845535
SEC Filing
0001749475-26-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free